Illegal veterinary medicines

Similar documents
Quality of veterinary medicines

Quality of veterinary medicines

Counterfeit drugs: Experience of West Africa

OIE AMR Strategy, One Health concept and Tripartite activities

The OIE activities to protect animal and human health: Potential contributions in the fight against counterfeit drugs

Regional Analysis of the OIE PVS Missions in South-East Asia with a focus on APFS

Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products

Dr Elisabeth Erlacher Vindel Head of Science and New Technologies Departement OIE AMR strategy and activities related to animal health

Private Sector Perspectives IFAH (worldwide)

OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials in Animals Part I

Quality of Veterinary Medicinal Products. How to ensure the quality of Veterinary Medicinal Products

FAO-OIE-WHO Tripartite Positions and Actions on Antimicrobial Resistance (AMR)

14th Conference of the OIE Regional Commission for Africa. Arusha (Tanzania), January 2001

Overview of the OIE PVS Pathway

Results of the questionnaire on Veterinary Medicinal Products in the Middle East Damascus, Syria, 2-4 December 2009

GOOD GOVERNANCE OF VETERINARY SERVICES AND THE OIE PVS PATHWAY

Global Communication on AMR in Animal Health: Tripartite and OIE Efforts

Antimicrobial Resistance at human-animal interface in the Asia-Pacific Region

RECENT ACTIVITIES OF THE NATIONAL FOCAL POINT FOR VETERINARY PRODUCTS - SWAZILAND PRESENTATION TO

Prudent use of antimicrobial agents Dairy Sector Initiatives. Robin Condron Dairy Australia

GARP ACTIVITIES IN KENYA. Sam Kariuki and Cara Winters

Illegal veterinary drugs. How to ensure the quality and traceability of Veterinary Medicinal Products

Dr Dooshima Kwange Department of Veterinary and Pest Control Services FMARD

Participatory diagnostics of animal health service delivery systems in Mali

Combating Antimicrobial Resistance: A Manufacturing Perspective

OIE Strategy on Antimicrobial Resistance and the need for new diagnostic tools

Vincent Brioudes OIE North Africa, Tunis Animal Welfare Strategy in North Africa

Southern and Estaern Title

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

The Integration of WTO Agreements into National Legislation: Case of the SPS Agreement

Action Plan Goal 2 Surveillance and Monitoring Strategies:

NOTIFICATION TO THE PARTIES

Second Meeting of the Regional Steering Committee of the GF-TADs for Europe. OIE Headquarters, Paris, 18 December 2007.

SAFE, SECURE AND CONTROLLED: MANAGING THE SUPPLY CHAIN OF ANTIMICROBIALS

EXPERIENCE ON ANTIMICROBIAL USE AND RESISTANCE IN KENYA

International Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals

ANTIMICROBIAL RESISTANCE AND NATIONAL ACTION PLAN FOR PRUDENT USE OF ANTIMICROBIALS Egypt, GOVS 2017

CHALLENGES FACED BY AH SECTOR AN INDIAN PERSPECTIVE

OIE activities on rabies: PVS, vaccine banks and the OIE twinning

OIE International Solidarity: General Overview

Council of the European Union Brussels, 13 June 2016 (OR. en)

World Organisation for Animal Health (OIE) Sub-Regional Representation for Southern Africa

Good governance and the evaluation of Veterinary Services

The PVS Tool. Part 4. Introduction to the concept of Fundamental Components and Critical Competencies

Collection of quantitative data on the use of antimicrobial agents including the establishment of an OIE database

Dr. Gérard Moulin AFSSA/ANMV OIE Collaborating Centre on Veterinary medicinal products BP FOUGERES CEDEX, FRANCE

Article 25. WHEREAS WHEREAS WHEREAS,

Dr A T Sigobodhla. Regional Workshop for OIE National Focal Points for Veterinary Products (Cycle V): Ezulwini, Swaziland, 6-8 December 2017

Building Competence and Confidence. The OIE PVS Pathway

in food safety Jean-Luc ANGOT CVO France

OIE Resolution and activities related to the Global Action Plan. Regional Seminar for OIE National Focal Points for Veterinary Products 4 th Cycle

RESPONSIBLE ANTIMICROBIAL USE

AT LLC Sumskiy Becon.

Benefit of a Strengthened Enabling Environnement for FMD Control

Session 1: An introduction to the new requirements under the Food and Drug Regulations affecting industry and health care practitioners who compound

Contents & results of 3 years of VMP FP training Susanne Münstermann OIE Scientific and Technical Department

YOU YOU WE NEED. To implement the new Antimicrobial Resistance campaign TO HANDLE ANTIMICR BIALS WITH CARE. October Veterinary Services

Quality of 2 nd line medicines for tuberculosis. Ms Lisa Hedman World Health Organization Department of Essential Medicines and Health Products

Animal medicines Dispelling the consumer myths. AHDA Conference 28 January Phil Sketchley Chief Executive National Office of Animal Health

Dr Stuart A. Slorach

WORLD ORGANIZATION FOR ANIMAL HEALTH /OIE/- ENGAGEMENT WITH ANIMAL WELFARE AND THE VETERINARY PROFFESSION

Fipronil in eggs: public health risk?

Action and Experience of Containment of AMR in Veterinary Sector JAPAN

Antimicrobial resistance. Summary of OIE Activities

QUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS

OIE mission in the framework of One Health Focus on antimicrobial resistance (AMR)

Technical assistance for the Animal Health Department of the KVFA and the Food and Veterinary Laboratory (Kosovo) - Deliverable 1.

The Challenges of Globalisation for Veterinary Education. Dr. David M. Sherman

OVER 30 MONTH CATTLE SLAUGHTER RULE (OTM Rule)

WILDLIFE DISEASE AND MIGRATORY SPECIES. Adopted by the Conference of the Parties at its Tenth Meeting (Bergen, November 2011)

Veterinary Services in Argentina

OIE standards on the Quality of Veterinary Services

ORDINANCE NO. CS-296

VICH:Organization,Guidelines and Global Outreach

Strategizing to manage emerging animal diseases in South Africa. Dr Pieter Vervoort, National Animal Health Forum chairperson

The Economics of Antibiotic Use in U.S. Livestock Agriculture

The Veterinary Epidemiology and Risk Analysis Unit (VERAU)

National Action Plan development support tools

WHO Global Surveillance and Monitoring System SSFFC Medical Products (Substandard, Spurious, Falsely labelled, Falsified and Counterfeit)

Multi- sectoral strategy for brucellosis control in peri- urban dairy production zones of West and Central Africa

Animal Health and Welfare policies in the EU Status quo and tendencies

Combat Antimicrobial Resistance

Work of Regional Representations supporting the implementation of the OIE standards on animal welfare

Benson Ameda President of the Association of Veterinary Technicians in Africa

Introduction SEAVDRAC. 23 October Prof G E Swan. Southern and Eastern African Veterinary Drug Regulatory Affairs conference

OIE standards on the use of antimicrobials and antimicrobial resistance monitoring

Assessment of compliance of current legislation: Veterinary Products Act

Evaluation of Performance of Veterinary Services - Viet Nam experience

QUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS

Veterinary Legislation and Animal Welfare. Tania Dennison and David M. Sherman

OIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017)

QUESTIONNAIRE FOR ADMINISTRATIONS [1], ASSOCIATIONS AND OTHER ORGANISATIONS

Investing in Human Resources in Veterinary Services

WHY A BAN IS THE ONLY OPTION FOR THIRD PARTY PUPPY SALES

OIE Standards on Veterinary Legislation: Chapter 3.4 of the OIE Terrestrial Animal Health Code

Antimicrobial Resistance, yes we care! The European Joint Action

RESIDUE MONITORING AND CONTROL PROGRAM. Dr. T. Bergh Acting Director: Veterinary Public Health Department Agriculture, Forestry and Fisheries

Development and improvement of diagnostics to improve use of antibiotics and alternatives to antibiotics

Sustainability : an opportunity for poultry production. Christine AGNES Elanco Food Chain Leader EMEA

VIETNAM S RESIDUE CONTROL PLAN FOR EXPORTING HONEY IN PRODUCTION, COLLECTION AND PROCESSING

Transcription:

Illegal veterinary medicines Regional Seminar for OIE National Focal Points for Veterinary Products Beirut, Lebanon, 7-9 November 2017 Philippe Sabot on behalf of HealthforAnimals. www.animalhealthmatters.org www.healthforanimals.org

Illegal veterinary medicines Contents Part 1: What we know about illegal veterinary medicines Part 2: What to do about it? How to achieve quality? 2

Part 1: What we know about illegal veterinary medicines? 3

What we know about illegal veterinary medicines? HealthforAnimals completed global study Report will be available in early 2018 Learn lessons from pharma, pesticide industries Report addresses: 1. Risks to animals, human health, society 2. Illegal veterinary medicine distribution chains 3. Controlling illegal veterinary medicines 4. Recommendations for actions Regulation and enforcement agencies Veterinarians Manufacturers of authorized medicines Retailers, wholesalers Farmers and pet owners 4

How we know it? It is illegal criminal activity - difficult to detect, investigate, quantify. The information we do have is based on 3 types of sources: 1. Law enforcement data and actions (and media coverage thereof) World Customs data, polices forces, Interpol Seizure of counterfeit veterinary products, 2013 China Fake veterinary drugs on the market, 2012 Uganda Makers of fake veterinary medicine uncovered, 2013 Vietnam 2. Some testing in some markets extrapolation testing in developed markets by governments and others FAO, OIE, etc. projects in other markets, particular Africa 3. Industry/veterinarians experiences in the market place sense of likely sizes of markets reps visiting vets, distributors, farmers, etc. 5

Different types of illegal veterinary medicines Authorized veterinary medicines are approved by regulators for the treatment and prevention of diseases/disorders, and includes vaccines and pharmaceutical drugs 6

Estimated value of illegal veterinary medicines 3 to 10 % 7

Negatives impacts on different groups 8

Characteristics of markets with illegal vet. meds. Farmers and veterinary services access to quality medicines is poor in remoter areas poorly funded local research institutes lack of awareness among livestock farmers - focus on price Distributors/importers weak distribution channels interest of small distributors is financial, not quality or return customers poor financial capacity of importers packaging of drugs is a limiting factor administrative procedures for imports long and bureaucratic Authorities no government policies or resources inadequate regulations and enforcement - lack of governance existing regulations not implemented solutions (medicines/vaccines) do not exist or not up to date 9

Illegal veterinary medicines main findings 1. There are illegal products in all countries different kinds and levels in different markets some types worse than others 2. This is likely a smaller problem than in human medicine production animals - not make economic sense to use substandard companion animals - people love them, why endanger their health smaller scale vet. market = lower profit margins = less criminal interest 3. There are incentives to make, sell use illegals in markets where: buyers are poorer and less informed about drawbacks criminal sellers are less likely to be caught/punished 4. Less illegal products in food-exporting countries because higher compliance/ enforcement in EU, US, Canada, etc. - illegal products mostly in companion market Sub-Saharan Africa sometimes 60%+ of products illegal 10

Counterfeiting of veterinary medicines in some geographies is a reflection of the sophistication of the market. Example of illegal veterinary products Veterinary drugs sold in an African village market (source of photos in presention: Dr. Albert Douffissa. Presentation What is Needed to Improve Availability to Good Quality Veterinary Drugs and Vaccines. ) 11

Part 2: What to do about it? How to achieve quality? 12

What action should be taken? 13

Why it is important to use quality veterinary meds.? Quality products important for farmers: if veterinary products don t work as they should, farmers lose animals lost animals = lower productivity = lost income Quality products important for producers, who are: responsible to ensure quality in design, development, manufacturing, distribution ensure that all sources of variability affecting a process are identified and managed producers reputation Quality products important for society: poor products = poor production (meat, milk, eggs) = lower national productivity reputational risk for country damages export capacity disease spreading threatens other regions and countries consumer health risk of poor quality or fake drugs (residues and zoonosis) environmental risk 14

How regulatory requirements contribute to fight illegal meds. Compliance with laws Good Manufacturing Practice or local manufacturing standards regulatory information update and information collection internal compliance system (check and balance) Distribution requirement local company involvement (e.g. restriction on vaccines) Infrastructure for delivery (e.g. special storing condition, narcotic product, and toxic product) Traceability product identification and record of delivery Training and record system at the regulation change periodical reminding new staff addition, and new roles 15

What industry is doing and going to do more? 1. Increase awareness and deliver an effective narrative 2. Collaborate with international and national enforcement agencies to raise priority of action 3. Improve utilization of data collection and analysis 4. Facilitate identification of authenticity 16

More information Carel du Marchie Sarvaas, HealthforAnimals Executive Director, carel@healthforanimals.org Phillippe Sabot, Boehringer Ingelheim, Philippe.SABOT@merial.com Photo credit: ILRI\Zerihun Sewunet www.animalhealthmatters.org www.healthforanimals.org 17